Asthma in Children |
Childhood Asthma |
Clinical Trial: A Study of an Intravenous Drug in Pediatric Patients with Acute Asthma
This study is not yet open for patient recruitment.
|
Purpose
This study will attempt to find out if the addition of an intravenous form of a drug that is already used for treating asthma in children, will help resolve asthma attacks faster than using the current standard care alone.
| Condition | Intervention | Phase |
|---|---|---|
| Asthma | Drug: Investigational Drug for the Treatment of Asthma | Phase II Phase III |
MedlinePlus related topics: Asthma
Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study
Eligibility
Ages Eligible for Study: 6 Years - 14 Years, Genders Eligible for Study: Both
Criteria
Inclusion Criteria:
- Children 6-14 years of age seeking treatment in emergency departments with acute asthma attacks
Exclusion Criteria:
Location and Contact Information
Please refer to this study by ClinicalTrials.gov identifier NCT00117338
Call For Information 1-888-577-8839
More Information
Study ID Numbers: 2005_026
Record last reviewed: July 2005
Last Updated: July 25, 2005
Record first received: July 5, 2005
ClinicalTrials.gov Identifier: NCT00117338
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-07-26
Record last reviewed: July 2005
Last Updated: July 25, 2005
Record first received: July 5, 2005
ClinicalTrials.gov Identifier: NCT00117338
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-07-26

Not Signed In -


